Skip to main content
logo
Divi's Laboratories Limited (NSE:DIVISLAB)
India flag India · Delayed Price · Currency is INR
6,403.50
-5.00 (-0.08%)
Mar 2, 2026, 3:30 PM IST

Divi's Laboratories Revenue

Divi's Laboratories had revenue of 26.04B INR in the quarter ending December 31, 2025, with 12.29% growth. This brings the company's revenue in the last twelve months to 103.14B, up 13.62% year-over-year. In the fiscal year ending March 31, 2025, Divi's Laboratories had annual revenue of 93.60B with 19.31% growth.

Revenue (ttm)
103.14B
Revenue Growth
+13.62%
P/S Ratio
16.48
Revenue / Employee
9.78M
Employees
10,542
Market Cap
1.70T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202593.60B15.15B19.31%
Mar 31, 202478.45B780.00M1.00%
Mar 31, 202377.67B-11.93B-13.31%
Mar 31, 202289.60B19.90B28.56%
Mar 31, 202169.69B15.75B29.20%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries568.09B
Aurobindo Pharma331.82B
Cipla279.67B
Zydus Lifesciences260.89B
Glenmark Pharmaceuticals165.10B
Alkem Laboratories142.53B
Mankind Pharma139.14B
Ipca Laboratories95.06B
Revenue Rankings

Divi's Laboratories News

More News